Published in Gene Therapy Weekly, January 13th, 2000
"Human breast cancer cells (OCUB-M), retrovirally transduced with granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin-2 (IL-2) or IL-4 gene were examined for their antitumor activities in nude mice," stated T. Maeda and colleagues from Chiba University, School of Medicine, Japan.
Maeda et al. published the results of their study in the International Journal of Oncology ("Loss of Tumorigenicity of Human Breast Cancer Cells Engineered to Produce IL-2, IL-4 or GM-CSF in Nude Mice,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.